SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) announced it will initiate FDA-enabling toxicology and pharmacology studies for its diabetes and ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions